The addition of hyaluronidase, an enzyme that hydrolyzes HA, sensitizes T-ALL cells to doxorubicin, suggesting that the chemoprotective effect of CD44 may require activation by HA ligand [18]. The gene discussed is CD44; the disease is acute lymphoblastic leukemia.